950-03-8

Upstream product

• 677-21-4 1,1,1-trifluoropropylene 
• 619-58-9 4-iodobenzoic acid 
• 90484-57-4 3,3,3-Trichlor-1-brom-1-<4-brom-phenyl>-propan 
• 882026-83-7 1-(4-Brom-phenyl)-(2-trichlormethyl)-ethylen 
• 433941-71-0 (E)-4-(3,3,3-trifluoroprop-1-enyl)benzenecarbonitrile 
• 57328-25-3 diphenyl(2,2,2-trifluoroethyl)phosphine oxide 
• 1571-08-0 methyl 4-formylbenzoate 
• 56148-65-3 trans-p-carboxycinnamic acid 
• 2926-29-6 Langlois reagent 
• 2039-82-9 1-bromo-4-ethenyl-benzene 
• 78622-58-9 trans-β-(trifluoromethyl)-4-(methoxycarbonyl)-styrene 
• 124-38-9 carbon dioxide 

Relevant academic research and scientific papers

Electrochemical Decarboxylative Trifluoromethylation of α, β-Unsaturated Carboxylic Acids with CF3SO2Na

A new method for the synthesis of vinyl trifluoromethyl compounds from α, β-unsaturated carboxylic acids and CF3SO2Na has been developed. This electrochemical decarboxylative trifluoro-methylation was found to be highly stereoselective and afforded products in good yields with wide substrate scope under metal-free and external chemical oxidant-free conditions.

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Abstract of the Disclosure Compounds are disclosed that have a formula represented by Formula I herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals in

AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Compounds are disclosed that have a formula represented by the following: Formula (I) The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, in